KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Cash from Financing Activities: 2009-2025

Historic Cash from Financing Activities for Idexx Laboratories (IDXX) over the last 16 years, with Sep 2025 value amounting to -$313.3 million.

  • Idexx Laboratories' Cash from Financing Activities fell 7.67% to -$313.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.0 billion, marking a year-over-year decrease of 39.47%. This contributed to the annual value of -$878.1 million for FY2024, which is 98.66% down from last year.
  • As of Q3 2025, Idexx Laboratories' Cash from Financing Activities stood at -$313.3 million, which was down 89.16% from -$165.6 million recorded in Q2 2025.
  • Over the past 5 years, Idexx Laboratories' Cash from Financing Activities peaked at -$13.5 million during Q1 2022, and registered a low of -$330.3 million during Q1 2025.
  • Its 3-year average for Cash from Financing Activities is -$193.6 million, with a median of -$165.6 million in 2025.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first plummeted by 41,763.32% in 2021, then spiked by 89.60% in 2022.
  • Over the past 5 years, Idexx Laboratories' Cash from Financing Activities (Quarterly) stood at -$165.8 million in 2021, then increased by 29.61% to -$116.7 million in 2022, then increased by 12.75% to -$101.8 million in 2023, then plummeted by 128.57% to -$232.8 million in 2024, then declined by 7.67% to -$313.3 million in 2025.
  • Its Cash from Financing Activities stands at -$313.3 million for Q3 2025, versus -$165.6 million for Q2 2025 and -$330.3 million for Q1 2025.